- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 337/08 - Compounds containing any of the groups e.g. thiosemicarbazides the other nitrogen atom being further doubly-bound to a carbon atom, e.g. thiosemicarbazones
Patent holdings for IPC class C07C 337/08
Total number of patents in this class: 49
10-year publication summary
|
6
|
6
|
8
|
5
|
0
|
3
|
0
|
1
|
1
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Neoculi Pty Ltd | 18 |
5 |
| Mateon Therapeutics, Inc. | 6 |
4 |
| Baylor University | 341 |
3 |
| The Research Foundation for The State University of New York | 1617 |
3 |
| Rutgers, The State University of New Jersey | 1895 |
3 |
| Ottawa Hospital Research Institute | 109 |
2 |
| Yuria-pharm Limited Liability Company | 3 |
2 |
| BASF SE | 20933 |
1 |
| The Regents of the University of California | 19918 |
1 |
| Syngenta Participations AG | 1903 |
1 |
| Albert Einstein College of Medicine, Inc. | 577 |
1 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2157 |
1 |
| Collaborative Medicinal Development, LLC | 9 |
1 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 946 |
1 |
| Howard University | 189 |
1 |
| Isis Innovation Limited | 496 |
1 |
| Istanbul Universitesi | 4 |
1 |
| Koc Universitesi | 155 |
1 |
| Merrimack Pharmaceuticals, Inc. | 88 |
1 |
| Molecular Discovery Systems | 2 |
1 |
| Other owners | 14 |